Combinatorial chemistry: a liquid-phase approach. (Q45978776)

18 December 2017

title

Combinatorial chemistry: a liquid-phase approach. (English)

1 reference

18 December 2017

author name string

Janda KD

series ordinal

1

1 reference

18 December 2017

Han H

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

18 December 2017

published in

Methods in Enzymology

1 reference

18 December 2017

volume

267

1 reference

18 December 2017

page(s)

234-247

1 reference

18 December 2017

Liquid Phase Synthesis of Peptides

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

HELP (high efficiency liquid phase) new oligonucleotide synthesis on soluble polymeric support

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

Trimethylsilyl iodide as a peptide deblocking agent

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

Removal of protected peptides from the Merrifield resin by potassium cyanide catalyzed transesterification

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

Novel sulfonamides as potential, systemically active antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2896%2967016-5

7 January 2021

10.1016/S0076-6879(96)67016-5

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017